This October, Jasmonate wears pink because the people affected by breast cancer deserve attention and respect. The ribbon also asks something of our science communication: enthusiasm must not turn a laboratory observation into a promise to a person. Our contribution is an accessible reading room for experimental jasmonate science, with the original papers close enough to inspect.
Hope can coexist with a question mark
A vivid research idea can make us want to announce the future before it arrives. Resist that temptation by naming the evidence stage in the first sentence. Cells in a dish, cells removed from a person, a mouse experiment and a clinical study are different kinds of evidence. They answer different questions. Scientific hope is strongest when readers can see which question was actually answered.
The breast cancer examples in our selected reading set concern cultured cells or a plant-material bioassay. The 2021 Bomer study uses plant genetics and cell experiments to explore bioactive mixtures. It does not test whether people who consume those plants have fewer cancers or better outcomes. That boundary belongs beside the finding, not hidden at the bottom of the page. (S07: primary paper)
Make one paper legible
Try a modest awareness-month exercise. Choose a primary paper. Write the exact compound or material used, the model, the comparison group and one measured endpoint. Add the figure or table that supports the result. Finally, write one thing the experiment cannot tell you. This turns a headline into a traceable claim.
A second exercise is to audit the nouns. Does a sentence say people when the paper studied cells? Does it say jasmonic acid when the experiment used methyl jasmonate? Does it say cure when the endpoint was a viability assay? Those substitutions can quietly change the meaning of a scientific result.
Respect the human context
People living with breast cancer do not need a storefront to imply that a download or a research chemical will improve their prognosis. Our paid products are reading aids: original summaries, source links and reusable research worksheets. They do not provide treatment instructions, dosing, personalized medical recommendations or access to a therapy.
The support-the-page offer supports this independent educational website. It is not a charitable donation receipt, a contribution to a clinical trial or a promise of funding laboratory research. A pink ribbon is a design and awareness choice. It does not imply endorsement by a cancer charity or a hospital.
Curiosity that can be checked
A responsible research community makes disagreement and uncertainty visible. The cell-line authentication work by Korch and colleagues offers a powerful example: model provenance can change how older results should be interpreted. A carefully kept research notebook has room for that change. (S09: primary paper)
For October, we invite readers to build a small, honest literature trail. Keep a source link with every claim. Record what you could verify and what you could not access. Return to uncertain findings when better evidence appears. The aspiration to contribute to cancer research is serious. The daily practice begins with reading well.
Limits to keep with the claim
- This is a research-literacy awareness editorial, not screening or treatment guidance.
- No charity affiliation or allocation of sales to clinical research is represented.
Sources and evidence
Open the primary paper and inspect its experimental setting. This selected reading list is not a systematic review or medical guidance.
- S07 / Jasmonates induce Arabidopsis bioactivities selectively inhibiting the growth of breast cancer cells through CDC6 and mTORPlant leaf-disk bioassay and cultured mammalian cells
Plant-derived mixtures and direct methyl jasmonate are different exposures. Exact active components require further identification. A leaf-disk cell bioassay does not establish that eating plants prevents or treats cancer.
DOI: 10.1111/nph.17031 - S09 / Authentication of M14 melanoma cell line proves misidentification of MDA-MB-435 breast cancer cell lineCell-line authentication and donor provenance study
This changes the tissue interpretation of older MDA-MB-435 work; it does not erase measurements in that line or invalidate results obtained separately in other authenticated models.
DOI: 10.1002/ijc.31067
